Gynecologic Oncology

University of Utah

Questions discussed in this category

Do you consider an ovarian cancer patient who progresses on PARP inhibitor, either for treatment or maintenance, to be platinum resistant regardless of time since last platinum based chemotherapy?

Does the exact time since last platinum-based chemotherapy change your answer?

1 Answer available

How do positive pelvic washings influence your decision to administer adjuvant therapy to early stage endometrial cancer who otherwise meets no criteria for adjuvant therapy?

<60y/o, grade 1 endometrioid endometrial cancer. TLH, BSO, sentinel nodes. Stage IA, focal LVSI, 20% myometrial invasion, negative sentinel nodes, ...

2 Answers available

Gynecologic Oncology

University of Utah

Questions discussed in this category

Related Topics in Gynecologic Oncology